All Type of News
RSA drugs are cruising after getting insurance benefits
RSA(Risk Sharing Agreement) drugs recorded increased in performance. Except for drugs newly registered as RSA drugs, most products are expected to record billions of sales.
Although the RSA system cannot be evaluate...
Emergency contraceptives decided to remain as ETC
The Korean Pharmaceutical Association(President Chan-hui Jo, KPA) expressed a deep regret for the Ministry of Food and Drug Safety’s(MFDS) decision to keep emergency contraceptives as ETC drugs.
Through a news releas...
Green Cross leads in manufacturing biopharmaceutical productsUnder the favorable conditions on vaccines and blood products, Green Cross has remained as the top in the biopharmaceutical manufacturing performance.
According to the ‘2015 B...
|
Biopharmaceutical product exports reach USD 990 million
Last year, the biopharmaceutical exports were recorded at USD 789.15 million, overcoming the imports of USD 738.22 million, switching the trade balance to surplus.
On the 23rd, the Ministry of Food and Drug Safety(M...
Celebrex 200mg and Miltaq voluntarily cut by 23% and 5% respectively
Multinational pharmaceutical companies have voluntarily cut prices of their major products. They are products, such as Celebrex Cap 200mg, Xalatan Eye Drops and Multaq Tab; their decrease range is 23.4% at the maximum...
Will Boehringer-Lilly’s ‘Jardiance’ bring new atmosphere in diabetes treatment market?
Boehringer Ingelheim and Lilly attracted attention as expected to actively enter the SGLT-2 inhibitor market through launching ‘Jardiance(generic name: empagliflozin).’
Boehringer Ingelheim Korea, Lilly Korea and Yuh...
Celltrion’s ‘Remsima’ to expand into Middle Eastern market, starting with Saudi Arabia
Celltrion acquired approval to sell Remsima from the Saudi Arabian regulatory authority, the Saudi FDA(Saudi Food and Drug Authority), on the 20th of April, and begun the sales from the 19th of Mar.
On a basis of the...
MFDS announces change order, temporarily wrapping up the ‘olmesartan’ issue
The Ministry of Food and Drug Safety(MFDS) held the Central Pharmacists Deliberation Committee, and announced the change order of the olmesartan’s approval after reviewing its relevant safety information.
According ...
Green Cross acquires the first tetravalent flu vaccine for multiple injections in KoreaOn the 23rd, Green Cross(CEO Eun-cheol Huh) announced product approval of ‘GCFlu Quadrivalent Multi Inj,’ an tetravalent influenza vaccine, from the Ministry of Food and Drug Sa...
|
Foreign companies tackling generic trademarks, such as Baracle and Lavix
Multinational pharmaceutical companies which claimed invalidation trials for trademark of generic drugs for the reason of confusion with their original products were defeated in a series.
Although the original compa...
